| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents, at carrying value | 9,243 | 3,466 | ||
| Restricted cash and cash equivalents, current | 26 | 25 | ||
| Prepaid expense, current | 1,739 | 1,683 | ||
| Other assets, current | 47 | 63 | ||
| Assets, current | 11,055 | 5,237 | ||
| Restricted cash, noncurrent | 55 | 53 | ||
| Deposits assets, noncurrent | 36 | 5 | ||
| Property, plant and equipment, net | 26 | 30 | ||
| Operating lease, right-of-use asset | 442 | 472 | ||
| Assets, noncurrent | 559 | 560 | ||
| Assets | 11,614 | 5,797 | ||
| Accounts payable, current | 946 | 692 | ||
| Operating lease, liability, current | 174 | 171 | ||
| Employee-related liabilities, current | 721 | 628 | ||
| Other accounts payable and accrued liabilities | 945 | 659 | ||
| Represent the amount of underwriting promissory notes in current liabilities | 0 | 0 | ||
| Represent the amount of private warrant to purchase ordinary shares | - | 0 | ||
| Liabilities, current | 2,786 | 2,150 | ||
| Operating lease, liability, noncurrent | 311 | 337 | ||
| Represent the amount of promissory notes to related parties | 1,540 | 3,190 | ||
| Liabilities, noncurrent | 1,851 | 3,527 | ||
| Liabilities | 4,637 | 5,677 | ||
| Common stock, value, issued | 42 | 8 | ||
| Additional paid in capital | 57,689 | 47,604 | ||
| Retained earnings (accumulated deficit) | -50,754 | -47,492 | ||
| Equity, attributable to parent | 6,977 | 120 | ||
| Liabilities and equity | 11,614 | 5,797 | ||
Silexion Therapeutics Corp (SLXNW)
Silexion Therapeutics Corp (SLXNW)